Diagnotics, IVD, Point of Care,
Thrixen has raised $7.0M in total funding. The most recent round was Seed. The last funding was announced in April 2024.
Thrixen's investors include 22Health Ventures, John Ballantyne.
Thrixen is headquartered in Singapore, Singapore.
Diagnotics, IVD, Point of Care,
Thrixen is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Thrixen — Funding & Investors." VCBacked, April 29, 2024, https://www.vcbacked.co/company/thrixen. Accessed September 15, 2026.
VCBacked. (2024). Thrixen — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/thrixen
{{cite web |title=Thrixen — Funding & Investors |url=https://www.vcbacked.co/company/thrixen |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated